Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: J Endocrinol Invest

Search In Journal Title:

Abbravation: Journal of Endocrinological Investigation

Search In Journal Abbravation:

Publisher

Springer International Publishing

Search In Publisher:

DOI

10.1007/bf00674867

Search In DOI:

ISSN

1720-8386

Search In ISSN:
Search In Title Of Papers:

Bilateral adrenal enucleationinduced changes in a

Authors: M J Perone A N Chisari C L Gómez Dumm E Spinedi F E Estivariz
Publish Date: 2014/03/27
Volume: 20, Issue: 4, Pages: 172-182
PDF Link

Abstract

The aim of the present study was to elucidate the modulatory effect of transient changes in endogenous glucocorticoids occurring after bilateral adrenal enucleation ENUC on anterior pituitary AP proopiomelanocortin POMCderived peptides synthesis and output in rats For this purpose adult female rats were either bilaterally ENUC adrenalelectomized ADX or shamoperated SHAM and killed by decapitation 2 7 14 and 21 days after surgery Trunk blood was collected for measurements of ACTH βendorphin βEND and corticosterone B concentrations APs were quickly dissected for the determination of ACTH βendorphin βENDlike βENDLI and γ3MSH contents and adrenal glands were removed and submitted to histological study The results indicate that ENUC and ADX increased AP POMCrelated peptides synthesis and release in association with changes in the AP processing of peptides belonging to the Nterminal γ3MSH mid ACTH and Cterminal βLPH/ENDs portions of POMC While ADX abolished plasma B levels ENUC induced a transient day 2 decrease in plasma B concentrations which returned to SHAM levels at 7 days after surgery These data tallied with the histological observations carried out indicating a timedependent regenerative process of the adrenal which was completed by three weeks after ENUC There was a different pattern in plasma ACTH and βEND levels between ENUC and ADX maximal plasma peptide levels were found 7–14 days after ENUC then falling down to SHAM values at 21 days post ENUC Conversely there was a constant increment in plasma peptide levels up to 21 days after ADX At 2 days after both ENUC and ADX all peptides measured in the AP were lower than SHAM values thus reflecting a rapid corticotrope secretion Thereafter 7 or more days after surgery AP peptide content in ADX rats increased in a timerelated fashion up to 21 days after surgery Only βENDLI showed a similar AP content to that of the SHAM group thereafter indicating a preferential cleavage of POMC to βEND long after ADX 21 days ENUC rats showed increased AP POMC peptides content throughout the whole time and it was significantly different from SHAM and ADX values 14 days postsurgery Interestingly we found an increment in AP γ3MSH a peptide which is preferentially synthesized in the intermediate lobe of the rat pituitary in both ENUC and ADX situations Our results further indicate that 1 glucocorticoids from regenerating adrenal origin induce a fast negative feedback mechanism on AP secretion and 2 there might be a delayed inhibitory action of newly synthesized corticosteroids on higher levels of the central nervous system The lack of glucocorticoids ADX clearly corroborates a persistent enhancement of AP POMCrelated peptides synthesis and secretion The differences in AP processing of POMC between ENUC and ADX might be due to qualitative/quantitative changes in hypotalamic ACTH secretagogues output


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure
  2. Intraventricular administration of estradiol modulates rat prolactin secretion and synthesis
  3. The effects of calcitonin on idiopathic nephrolithiasis. Evidence of bone involvement in fasting hypercalciuria
  4. Non-palpable thyroid nodules in a borderline iodine-sufficient area: Detection by ultrasonography and follow-up
  5. Environmental car exhaust pollution damages human sperm chromatin and DNA
  6. Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease
  7. Thyroidal release after oral administration of TRH in normal subjects
  8. Hypopituitarism in Langerhans cell histiocytosis: Seven cases and literature review
  9. Regulation of mouse placental lactogen-II secretion by transforming growth factor-α after midpregnancy
  10. Amiodarone-induced thyrotoxicosis suggestive of thyroid damage
  11. Effect of thyroxine on synaptotagmin 1 and SNAP-25 expression in dorsal hippocampus of adult-onset hypothyroid rats
  12. Diagnosis of lung carcinoid with cutaneous hyperpigmentation eight years after bilateral adrenalectomy
  13. Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy
  14. Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women
  15. Evaluation of goiter using ultrasound criteria: A survey in a middle schoolchildren population of a mountain area in Central Italy
  16. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity
  17. Somatostatin analogs in the treatment of medullary thyroid carcinoma
  18. Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma
  19. Expression of hypothalamic corticotropin-releasing hormone-like immunoreactivity in isolated ACTH deficiency: A report of an autopsied case
  20. Pilot study for congenital hypothyroidism, preliminary report
  21. Management of recurrent hyperthyroidism in patients with Graves’ disease treated by subtotal thyroidectomy
  22. Changes of pituitary and penile structure in male adult rats following castration and high-fat diet
  23. CD38 autoimmunity: Recent advances and relevance to human diabetes
  24. Immunological pattern in patients with 21-hydroxylase deficiency
  25. Circadian blood pressure profile in patients with Cushing’s syndrome before and after treatment
  26. Diagnostic difficulties in long-standing insulinoma with near-normal plasma insulin levels
  27. Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management
  28. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD)
  29. Effects of perinatal hypothyroidism on rat behavior and its relation with apoptosis of hippocampus neurons
  30. Evaluation of the anterior pituitary function in the acute phase after spontaneous subarachnoid hemorrhage
  31. Effects of recombinant human interferon gamma on human thyroid tissues from patients with Graves’ disease and normal subjects transplanted into nude mice
  32. Development of a meningioma in a patient with acromegaly during octreotide treatment: Are there any causal relationships?
  33. Intrinsic abnormality of thyroid cells from a patient with a Brobdingnagian goiter
  34. Comparison of immuno- and HPLC-assays for the measurement of urinary collagen cross-links
  35. Effect of bromocriptine administration on gastric acid and gastrin secretion in man
  36. Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing’s syndrome
  37. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison’s disease
  38. Effect of chronic bromocriptine administration on tumor size in patients with “nonsecreting” pituitary adenomas
  39. Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome
  40. Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves’ disease model
  41. Human placental Δ 5 -3β-hydroxysteroid dehydrogenase, Δ 4,5 isomerase: in vitro effect of dehydroepiandrosterone and allylestrenol
  42. Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis
  43. BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency
  44. Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population?
  45. Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?
  46. Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients
  47. Are extremely high progesterone levels still an issue in IVF?
  48. Gestational diabetes mellitus: an updated overview
  49. Effects of a 16-week progressive high-intensity strength training (HIST) on indexes of bone turnover in men over 65 years: A randomized controlled study
  50. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations
  51. The gonadal function in obese adolescents: review
  52. Androgen producing adrenal adenoma. Report on a case associated with hyperparathyroidism
  53. Diagnosis of Cushing’s syndrome: Re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group
  54. Feeding behavior during long-term hexarelin administration in young and old rats
  55. Serum hepatocyte growth factor is increased in Hashimoto’s thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals
  56. Transition from pediatric to adult care of children with chronic endocrine diseases: A survey on the current modalities in Italy
  57. TTF-2/FOXE1 gene polymorphisms in Sicilian patients with permanent primary congenital hypothyroidism
  58. Regulation of 86 Rb + outflow from pancreatic islets III. Possible significance of ATP
  59. Involvement of interleukin-1 in the inhibition of in vivo insulin release: possible role of adrenal glands
  60. Growth and endocrine function in thalassemia major in childhood and adolescence
  61. In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine
  62. In the rat, estrone sulphate is the main serum metabolite of oral oleoyl-estrone
  63. Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay
  64. Riedel’s thyroiditis associated with Hashimoto’s thyroiditis, hypoparathyroidism, and retroperitoneal fibrosis
  65. Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects
  66. Effects of gonadotropin-releasing hormone (GnRH) on gastric secretion and gastrin release in the dog
  67. Update on parathyroid carcinoma
  68. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population
  69. Assessment of growth hormone insulin like growth factor-I axis in Down’s syndrome
  70. Mutations of the human thyrotropin-ß subunit glycosylate site reduce thyrotropin synthesis independent of changes in glycosylate status
  71. Abnormal thyroid stimulating hormone following pituitary surgery
  72. Epidemiological, clinical, and genetic characteristics of Paget’s disease of bone in a rural area of Calabria, Southern Italy
  73. Effect of low-dosage recombinant human growth hormone therapy on pulmonary function in hypopituitary patients with adult-onset growth hormone deficiency
  74. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention
  75. Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment
  76. Growth hormone status in morbidly obese subjects and correlation with body composition
  77. Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism
  78. Adiponectin is associated with serum and adipose tissue fatty acid composition in rats
  79. Analysis of the vitamin D receptor FokI polymorphism
  80. Proteomic analysis of human thyroid fine needle aspiration fluid
  81. Bromocriptine induced pregnancy in two cases of euprolactinemic hypothalamic amenorrhea
  82. Bromocriptine induced pregnancy in two cases of euprolactinemic hypothalamic amenorrhea
  83. The dissociation of the exaggerated prolactin and thyrotropin responses in seminiferous tubule failure following the administration of a double-pulse of thyrotropin-releaslng hormone
  84. Neonatal androgenization increases vasoactive intestinal peptide levels in rat anterior pituitary: possible involvement of vasoactive intestinal peptide in the neonatal androgenization-induced hyperprolactinemia
  85. Improvement of metabolic syndrome markers through altitude specific hiking vacations
  86. Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1
  87. Impairment of GH secretion in amyotrophic lateral sclerosis is not affected by riluzole treatment
  88. Free androgen index and Irisin in polycystic ovary syndrome
  89. A case of acute suppurative thyroiditis complicated by thyrotoxicosis

Search Result: